- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Andrew Armstrong, MD, Professor of Medicine, Professor in Surgery, Professor in Pharmacology and Cancer Biology, Director of Research, Duke University, Durham, NC Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC. Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: A. Oliver Sartor, MD, Disease Group Leader GU Cancers, Director of Radiopharmaceutical Trials, Mayo Clinic, Rochester, MN Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Atlantic Urology Clin...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farber Cancer Institute, Boston, Massachusetts Rana R. McKay, Medical Oncologist, Associate Professor, University...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Brenda Martone, MSN, ANP-BC, AOCNP, Adult Nurse Practitioner, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Brenda Martone, MSN, ANP-BC, AOCNP, Adult Nurse Practitioner, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center...
|
- Details
- Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies: Robert Dreicer, MD, MS, MACP, FASCO, Head, Medical Oncology Section, Deputy Director University of Virginia Comprehensive Cancer Center, Associate Director for Clinical Research, Co-Director Paul Mellon Urologic Oncology C...
|
